Device Trial Radar · NCT06174805
AXIOS™ Gastroenterostomy for Gastric Outlet Obstruction IDE
Last checked: Nov 20, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Suspended
Enrollment
67
Planned (sponsor's estimate)
Start
Feb 11, 2025
Primary completion
Sep 2027
Study completion Sep 2027
Sponsor
- Lead sponsor
- Boston Scientific CorporationPublic (BSX)
- Sponsor type
- Industry
- First posted
- Dec 18, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To investigate the safety and technical success of EUS-guided gastroenterostomy (EUS-GE) using the AXIOSTM lumen-apposing Metal Stent for the management of symptoms associated with gastric outlet obstruction from malignant unresectable neoplasm.
Conditions
- Gastric Outlet Obstruction
Interventions
AXIOS(TM) Stent and Electrocautery Enhanced Delivery SystemDevice
Patients who meet all the inclusion criteria and none of the exclusion criteria will have a EUS-guided gastroenterostomy (EUS-GE) using the AXIOS(TM) lumen-apposing Metal Stent for the management of symptoms associated with gastric outlet obstruction from malignant unresectable neoplasm
Primary outcomes
What the sponsor says the trial is designed to measure.
- Serious Adverse EventsTime frame: Through study completion, an average of 1 year
- Technical SuccessTime frame: During the procedure
- Primary Effectiveness EndpointTime frame: through 14 days after procedure
Locations
10 sites in 6 countries. Site status is shown where the registry gives one.
Brigham and Women's Hospital
Boston, Massachusetts
Mayo Clinic
Rochester, Minnesota
New York Presbyterian/ Weill Cornell Medical Center
New York, New York
7 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.